Company
Lifeward
Lifeward (formerly ReWalk Robotics, Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr.
- Founded
- 2001
- HQ
- Marlborough, MA, USA / Yokneam Ilit, Israel
- Status
- public (NASDAQ: LFWD; formerly ReWalk Robotics, RWLK)
Models
2
Overview
Lifeward (formerly ReWalk Robotics, Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.
Verified record
- Verified deployments
- None on file
- Active incidents
- 3 incidents on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
CEO
Mark Grant (since June 2025)
Previous CEO
Larry Jasinski
CFO
Mike Lawless
Founder
Dr. Amit Goffer (deceased) — quadriplegic Israeli inventor
Ticker
NASDAQ: LFWD
Revenue 2024
Approximately 25.3 million USD
Units deployed
131 rehabilitation units + 689 personal exoskeleton units (as of Dec 2024)
FDA clearance
ReWalk 7 cleared March 2025; first FDA-cleared exoskeleton in 2014
Medicare
CMS reimbursement pathway established 2024
Operations
United States, Israel, Germany
Product portfolio
ReWalk 7, ReWalk Personal 6.0, AlterG Anti-Gravity, ReStore Exo-Suit, MyoCycle FES
Data & sources
Company filings
1
Press releases
3
Web sources
1
5 sources backing this record.View all →
Models (2)
View all models →Current platform
ReWalk 7
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Current platform
ReWalk Personal 6.0
ReWalk's Personal 6.0 is a powered lower-limb exoskeleton for individuals with spinal cord injury; servos at the hips and knees provide walking power, while accelerometers detect weight shifts to trigger each step. The onboard computer, sensors, and batteries are carried in a slimmed-down pack.
Current leadership (5)
- Joseph Turk Chairman of the Board
- Mike Lawless CFO
- Mark Grant President & CEO
- Larry Jasinski CEOsince 2012-01-01secondary-verified
- Amit Goffer Founder & Chief Innovation Officersince 2001-01-01secondary-verified
Founders (3)
- Amit Goffersolefounded 2001-01-01no longer at company
- Amit Goffersoleno longer at company
- Dr. Amit Gofferno longer at company
Former / Previously (2)
- Amit Goffer Foundersecondary-verified
- Dr. Amit Goffer Founder & Inventor
Safety record
2 recalls and 1 incident on record (3 serious). Most recent: Feb 2020.
Most recent: Feb 2020
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Lifeward (3)
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Lifeward in third-party press
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- ATOUN1 model
- B-TEMIA1 model
- Bionik Laboratories1 model
Supplied by (1)
Actuators & motors
- maxon Groupvia ReWalk Personal 6.0RE 40 brushed DC motors + GP 42 C planetary gearheads (ceramic), four units (hip + knee)supplies
Inbound supply edges feeding this company directly or via the models it owns. Same source bar as the outbound view (verified against at least two strong sources).
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Sources (5)
- https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward
- https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/
- Lifeward Names Mark Grant as New CEO · https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo
- Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market · https://golifeward.com/blog/lifeward-launches-sales-of-the-rewalk-7-personal-exoskeleton-in-u-s-market/
- Lifeward Ltd. SEC Filing 2025 · https://www.sec.gov/Archives/edgar/data/1607962/000117891325000736/zk2532799.htm
Common questions
- What is Lifeward?
- Lifeward (formerly ReWalk Robotics, Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.
- What does Lifeward make?
- Lifeward has 2 robot models on the DEPLOY registry: ReWalk 7, ReWalk Personal 6.0 (Lifeward builds physical robots).
- Is Lifeward publicly traded?
- Yes. Lifeward is publicly traded on public markets, per the DEPLOY registry.
- Who competes with Lifeward?
- On the DEPLOY registry, peer companies to Lifeward building in the same form factors include Honda, Ekso Bionics, German Bionic, ATOUN.
- Where is Lifeward headquartered?
- Lifeward is headquartered in Marlborough, MA, USA / Yokneam Ilit, Israel.
- Where does Lifeward operate robots?
- Lifeward is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Lifeward a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Lifeward ranks in roughly the top 27% of companies tracked by the registry.
- When was Lifeward founded?
- Lifeward was founded in 2001.
- Are there any incidents involving Lifeward?
- 3 active incidents involving Lifeward are on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
- Is Lifeward safe?
- Lifeward has 3 active incidents on record in the DEPLOY registry. 2 recalls and 1 incident on record (3 serious). Most recent: Feb 2020. Retracted incidents are excluded from this count.
Methodology: Verified · 5 sources (4 primary) · last reviewed 2026-07-09
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-09
Sources by quality tier
- 3
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
- 1
- primary-sec-filing
- SEC filing
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Lifeward.Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- ATOUN1 model
- B-TEMIA1 model
- Bionik Laboratories1 model
In the press
Recent coverage mentioning Lifeward from third-party publications. Automatically surfaced; not part of the verified registry record.
Lifeward's ReWalk Personal Exoskeleton Now Covered by Aetna
Aetna approves coverage for the ReWalk Personal Exoskeleton System, an FDA-approved technology for individuals with spinal cord injury, expanding insurance access.
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
A major US commercial health insurance company approves payment for a ReWalk 7 Personal Exoskeleton for one of its beneficiaries, expanding access beyond Medicare.
Lifeward Names Mark Grant as New CEO
Lifeward appoints Mark Grant, former Medtronic VP, as new CEO effective June 2 2025, replacing Larry Jasinski who transitions to advisory role.
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
Lifeward launches the ReWalk 7 Personal Exoskeleton nationwide in the US, featuring cloud connectivity, customizable walking speeds, and FDA clearance received in March 2025.
FDA Issues Clearance for ReWalk 7 Exoskeleton
Lifeward receives FDA clearance for the ReWalk 7 Personal Exoskeleton, building on the company historic first FDA clearance for a personal exoskeleton in 2014.
Machine-readable surfaces
- Markdown mirror: /companies/lifeward.md
- RSS feed: /companies/lifeward/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/4421900a-d71f-407e-a37c-ad1e3905e97f
- Revision history: /companies/lifeward/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- ATOUN1 model
- B-TEMIA1 model
- Bionik Laboratories1 model
Reality vs attention
Lifeward draws attention at the 54th percentile but verifies reality at the 75th percentile among exoskeletons. Hype Gap -21, 9th widest among exoskeletons.
Analysis
Safety profile within acceptable range for category. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 14, 2026